Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials †
Titel:
Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials †
Auteur:
van Soest, R.J. Templeton, A.J. Vera-Badillo, F.E. Mercier, F. Sonpavde, G. Amir, E. Tombal, B. Rosenthal, M. Eisenberger, M.A. Tannock, I.F. de Wit, R.